⌘K

Home/Filings/4/0001178913-18-001371

4//SEC Filing

Grossman David 4

Accession 0001178913-18-001371

CIK 0001641631other

View on SEC.gov Company Profile

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 5:40 PM ET

Size

11.0 KB

Accession

0001178913-18-001371

Insider Transaction Report

Form 4

Period: 2018-02-16

AIT Therapeutics, Inc.AITB

Director

Transactions

Exercise/Conversion
Common Stock
2018-02-16$4.25/sh+2,342$9,954→ 4,008 total
Purchase
Tranche B Warrant (right to buy)
2018-02-16$0.01/sh+2,342$23→ 2,342 total
Exercise: $4.25From: 2018-02-16Exp: 2021-02-15→ Common Stock (2,342 underlying)
Exercise/Conversion
Tranche A Warrant (right to buy)
2018-02-16−2,342→ 0 total
Exercise: $4.25From: 2018-02-16Exp: 2018-02-19→ Common Stock (2,342 underlying)
Purchase
Tranche A Warrant (right to buy)
2018-02-16$0.01/sh+2,342$23→ 2,342 total
Exercise: $4.25From: 2018-02-16Exp: 2018-02-19→ Common Stock (2,342 underlying)

Documents

1 file

4
zk1821566.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

AIT Therapeutics, Inc.

CIK 0001641631

Entity typeother

Related Parties

1

filerCIK 0001707106

Filing Metadata

Form type: 4
Filed: Apr 29, 8:00 PM ET
Accepted: Apr 30, 5:40 PM ET
Size: 11.0 KB

View on SEC.gov